Spyre Therapeutics
SYRE
SYRE
103 hedge funds and large institutions have $1.21B invested in Spyre Therapeutics in 2024 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
33% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 15
602.06% less ownership
Funds ownership: 691.63% → 89.57% (-602%)
Holders
103
Holding in Top 10
5
Calls
$76K
Puts
–
Top Buyers
| 1 | +$81.1M | |
| 2 | +$21.4M | |
| 3 | +$15.6M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$13.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$13.5M |
Top Sellers
| 1 | -$21.4M | |
| 2 | -$19.9M | |
| 3 | -$19.1M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$14.8M |
| 5 |
GEM
Global Endowment Management
Charlotte,
North Carolina
|
-$14.3M |